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Pooled Association Tests for Rare Variants
in Exon-Resequencing Studies
Alkes L. Price,1,2,3,6 Gregory V. Kryukov,3,4,6 Paul I.W. de Bakker,3,4 Shaun M. Purcell,3,5 Jeff Staples,3,4
Lee-Jen Wei,2 and Shamil R. Sunyaev3,4,*
Deep sequencing will soon generate comprehensive sequence information in large disease samples. Although the power to detect asso-
ciation with an individual rare variant is limited, pooling variants by gene or pathway into a composite test provides an alternative
strategy for identifying susceptibility genes. We describe a statistical method for detecting association of multiple rare variants in
protein-coding genes with a quantitative or dichotomous trait. The approach is based on the regression of phenotypic values on indi-
viduals’ genotype scores subject to a variable allele-frequency threshold, incorporating computational predictions of the functional
effects of missense variants. Statistical signiﬁcance is assessed by permutation testing with variable thresholds. We used a rigorous pop-
ulation-genetics simulation framework to evaluate the power of the method, and we applied the method to empirical sequencing data
from three disease studies.Introduction
GWAS have successfully identiﬁed hundreds of loci
harboring common variants that are reproducibly associ-
ated with complex traits. However, common variants iden-
tiﬁed to date typically explain only a small fraction of over-
all heritability, motivating interest in low-frequency or rare
variants that may contribute to genetic risk.1,2 Technolog-
ical advances in high-throughput sequencing platforms
will soon make it possible to extend association studies to
low-frequency and rare variants, particularly in targeted re-
sequencing of exons.3,4 Rare variants are predicted to be en-
riched for functional alleles and to exhibit stronger effect
sizes than common variants, consistent with the view
that functional allelic variants are subject to purifying selec-
tion pressure.5–7 Deep-resequencing studies of candidate
genes have already demonstrated the effect of rare alleles
on several complex traits of biomedical relevance.8–14
The statistical power to detect phenotypic association
with an individual rare variant is limited, due to the small
number of observations for any given variant and a more
stringent multiple-test correction as compared to common
variants. This motivates analytical approaches that test the
combined effect of multiple rare variants, but this requires
prior speciﬁcation of which variants to combine into the
test. To date, most candidate-gene resequencing studies
have compared the number of individuals carrying alleles
exclusive to either of thephenotypic extremes. This strategy
effectively eliminates common alleles from the test because
theywouldbepresent in individuals atbothextremesunless
they have enormous effect. For large sample sizes, however,
limiting the association analysis to exclusive alleles may
unnecessarily reduce the statistical power of the test.1Department of Epidemiology, Harvard School of Public Health, Boston, MA 0
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frequency threshold and perform an association test on
the set of variants below that threshold, giving them
each equal weight (more generally, variants can be
collapsed into multiple frequency bins).15 Another
approach is to weight counts of each variant on the basis
of the estimated variance under the null hypothesis of
no association.16 This scheme applies much higher
weights to very rare variants, and it implicitly assumes
that the log odds ratio is approximately inversely propor-
tional to the square root of the allele frequency, as we
show below.
Using population-genetics simulations informed by
empirical sequencing data, we analyzed the relationship
between the phenotypic effect and the allele frequency
of a mutation within an evolutionary model that incorpo-
rates purifying selection. These simulations highlighted
the potential value of a statistical approach that uses a vari-
able allele-frequency threshold instead of a ﬁxed
threshold. We have implemented such an approach, as-
sessing statistical signiﬁcance by permutation testing
with variable thresholds, and we show that this approach
indeed improves statistical power in both simulated and
empirical data sets. In particular, this approach does not
make implicit assumptions about the relationship between
allele frequency and odds ratio.
Next, we have incorporated computational predictions
of the functional effect of amino acid changes17,18 in the
statistical test. The test gives higher weight to allelic vari-
ants predicted to be functionally signiﬁcant and lower
weight to variants predicted to be functionally insigniﬁ-
cant. We show that incorporating computational predic-
tions of functional importance further boosts power.2115, USA; 2Department of Biostatistics, Harvard School of Public Health,
s, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA;
ital, Harvard Medical School, Boston, MA 02115, USA; 5Center for Human
Genetics. All rights reserved.
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Table 1. Power of Various Approaches Using Quantitative
Phenotypes
T1 T5 WE VT VTP
a ¼ 0.001 0.137 0.182 0.098 0.204 0.259
a ¼ 0.05 0.547 0.503 0.543 0.600 0.686
We display results for T1 (1% allele-frequency threshold), T5 (5% allele-
frequency threshold), WE (weighted), VT (variable threshold), and VTP (VT
plus Polyphen) analyses for a ¼ 0.001 and a ¼ 0.05 significance levels, based
on 10,000 independent simulations.
Table 2. Power of Various Approaches Using Dichotomous
Phenotypes
T1 T5 WE VT VTP
a ¼ 0.001 0.089 0.150 0.078 0.161 0.213
a ¼ 0.05 0.482 0.458 0.488 0.533 0.625
As in Table 1, we display results for T1, T5, WE, VT, and VTP analyses for
a ¼ 0.001 and a ¼ 0.05 significance levels, based on 10,000 independent
simulations.Material and Methods
Simulation Framework
The demographic history and distribution of selection coefﬁcients
associated with de novo missense mutations were determined by
analyzing resequencing data from individuals of European
ancestry, as described previously.4 The parameters of the demo-
graphic-history model included ancestral population size,
bottleneck population size, ﬁnal population size, and duration
of exponential growth. The missense-to-synonymous ratio for de
novo mutations was assumed to equal 2.3 (see 4). The model was
shown to recapitulate the site-frequency spectrum of nonsynony-
mous human SNPs. We note that exponential population growth
and purifying selection are critical features of the model for the
analysis of rare alleles. We used this population-genetics model
to generate 9 kb of sequence data in each of 10,000 individuals.
We considered only missense mutations; nonsense, frameshift,
and splice-site mutations were not simulated. Corresponding
phenotypes were generated as follows: individuals that harbored
a missense mutation with an associated selection coefﬁcient
greater than s had a normal distribution of quantitative trait
values, with the same variance as noncarriers but with a mean
shifted by d standard deviations. Although the use of a discrete
cutoff on selection coefﬁcients for assigning function is clearly
an oversimpliﬁcation, we believe that this will not affect our
results because selection coefﬁcients do not explicitly enter into
any of our association tests, which consider only weakly related
variables. We generated data for 10,000 independent simulations
for each of s ¼ 0.0001, s ¼ 0.001, and s ¼ 0.01. (We note that
the choice of s affects not only the average selection coefﬁcient
associated with damaging missense mutations but also the frac-
tion of missense mutations that affect phenotypes.) In each case,
we simulated 3 kb of sequence for each of d ¼ 0.125, d ¼ 0.25,
and d ¼ 0.5. Our main results (Tables 1 and Table 2) focus on
d ¼ 0.25, which is intermediate between values characteristic for
relatively common SNPs segregating in the population (< 0.05
standard deviations [SD]) and mutations associated to Mendelian
syndromes (> 1 SD), and on s ¼ 0.001, which is close to the
median value for s estimated from empirical data.4 We note that
values of s and d, rather than average values for segregating alleles,
were speciﬁcally chosen to model new missense mutations.
Weighted Approaches Correspond to Implicit
Assumptions about Log Odds Ratios
We derive the result that a log likelihood ratio for a causal model
with speciﬁed odds ratios will weight counts of variants in propor-
tion to their log odds ratios. For SNP i (i¼ 1 tom), suppose that the
allele frequency pi in controls is known, let Ri be the odds ratio in
the causal model, and suppose that observed counts in cases are Ci
copies of the reference allele and Ni  Ci copies of the variant
allele. It follows that the allele frequency qi in cases under the
causal model is qi¼ Ripi / [1þ (R 1)pi], so that the likelihood ratio
for the causal model versus the null model is
Ym
i¼1

qi
pi
Ci1 qi
1 pi
NiCi
¼
Ym
i¼1

Ri
1þ ðRi  1Þpi
Ci 1
1þ ðRi  1Þpi
NiCi
:
Thus, conditional on the total counts Ni, the log likelihood ratio
is proportional to
Pm
i¼1
CilogðRiÞ. It follows that the weights
1=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
pið1 piÞ
p
for Ci proposed by
16 correspond to the implicit
assumption that logðRiÞ  1=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
pið1 piÞ
p
. (We note that this rela-The Ametionship between log odds ratio and allele frequency was also
assumed in the simulations of 16.)
Fixed-Threshold Approach
For dichotomous phenotypes, we computed the score
Pm
i¼1
xiCi, in
which i indexes SNPs, Ci is the reference allele count of SNP i in
cases, and xi is an indicator variable that is equal to 1 if the
frequency of SNP i is below a speciﬁed threshold (1% or 5%) and
is equal to 0 otherwise. Statistical signiﬁcance was assessed by
permutations on phenotypes. We generalize this to quantitative
phenotypes by computing
Pm
i¼1
Pn
j¼1
xiCijpj, in which j indexes
samples, Cij is the reference allele count of SNP i in sample j, and
pj is the phenotype of sample j.
Weighted Approach
For dichotomous phenotypes, following 16 we computed the score
Pm
i¼1
xiCi, in which xi ¼ 1=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
pið1 piÞ
p
is the inverse square root of ex-
pected variance based on allele frequencies pi computed from
controls only, with pseudocounts (see Equation 1 of 16). Statistical
signiﬁcance was assessed by permutations on phenotypes. We
generalize this to quantitative phenotypes by computing
Pm
i¼1
Pn
j¼1
xiCijpj, in which xi is now based on allele frequencies
pi computed from all samples, with pseudocounts.
Variable-Threshold Approach
We propose a variable-threshold approach. The intuition behind
this approach is that there exists some (unknown) threshold T
for which variants with a minor allele frequency (MAF) below T
are substantially more likely to be functional than are variants
with an MAF above T. Thus, we compute a z-score z(T) for each
allele-frequency threshold T, deﬁne zmax as the maximum z-score
across values of T, and assess statistical signiﬁcance of zmax by
permutations on phenotypes, allowing zmax in permuted data to
be attained at values of T different than those in unpermuted
data to ensure the validity of the permutation test. In contrast torican Journal of Human Genetics 86, 832–838, June 11, 2010 833
the ﬁxed-threshold approach, it is necessary for z(T) to account
for the fact that the variances of relevant sums vary with different
values of T, which will be compared when computing zmax. Thus,
for either dichotomous or quantitative phenotypes, we compute
z(T) as the z-score of a regression across samples of phenotypes
versus counts of mutationsmeeting the allele-frequency threshold
T. For computational speedup, we use linear regression instead of
logistic regression, letting xTi be an indicator variable that is equal
to 1 if the frequency of SNP i is below the threshold T and equal
to 0 otherwise, letting p be the mean value of pj across samples
j, and deﬁning zðTÞ ¼ Pm
i¼1
Pn
j¼1
xTi Cijðpj  pÞ=½
Pm
i¼1
Pn
j¼1
ðxTi CijÞ21=2, which
is proportional to a standard normal variable.
We used 1000 permutations in all of our simulations. In the case
of dichotomous phenotypes, ties between zmax in permuted and
unpermuted data may arise. These ties were broken randomly to
ensure an appropriate uniform distribution for permutation statis-
tics under null data. We deﬁne a p value as (x þ 1) / (P þ 1), in
which P is the total number of permutations and x is the number
of permutations for which zmax is higher in unpermuted data than
in permuted data.
The use of multiple allele-frequency thresholds in a permuta-
tion-testing framework raises questions as to the computational
complexity of this approach. However, by aggregating partial
sums for increasing values of allele frequency T, starting with
singleton mutations and continuing with only those values of T
corresponding to allele frequencies of actual SNPs, the computa-
tional cost for analyzing a single gene is proportional only to the
total number of minor alleles observed times the number of
permutations tested. For each of our simulations involving one
gene, 10,000 individuals, and 1000 permutations, running time
was roughly 1 s, which is scalable to genome-wide studies of
20,000 genes. Although a larger number of permutations may be
desired for the achievement of genome-wide signiﬁcance, these
can be limited to genes with suggestive evidence of association
on the basis of 1,000 permutations, a standard approach to permu-
tation testing in GWAS.
Cheating Approach to Incorporating 4(p)
We investigated the potential advantage of explicitly capturing
the relationship between allele frequency and functional effect,
via a ‘‘cheating’’ approach that weights variants according to the
probability 4(p) that an allele of frequency p is functional, as in-
ferred by using the same simulated data used to evaluate power.
We implemented the cheating approach for quantitative pheno-
types, using the weighted score
Pm
i¼1
Pn
j¼1
xiCijpj, in which xi ¼ 4ðpiÞ
was computed with the use of binned values from simulations.
Statistical signiﬁcance was assessed by permutations on pheno-
types.
Incorporation of Computational Predictions
of Functional Effects
We investigated whether incorporation of PolyPhen-2 scores
improves our statistical test.17,18 We calculated distribution of Pol-
yPhen-2 probabilistic scores for neutral and damaging amino acid
changes. For the neutral set we used amino acid substitutions that
were ﬁxed in the human lineage after divergence from chim-
panzee, and for the damaging set we used known disease-causing
missense mutations that cause the same phenotype as do
nonsense mutations in the same gene. From these two distribu-834 The American Journal of Human Genetics 86, 832–838, June 11,tions we determined posterior probabilities p(S) of being func-
tional for each SNP, given raw PolyPhen-2 probabilistic score S.
These recalibrated posterior probabilities p(S) were applied as
weights in the regression. We used the PolyPhen-2 predictions
only for rare variants (MAF < 1%), applying a constant weight
of 0.5 for low-frequency or common variants (1.0 for nonsense,
frameshift, and splice-site variants, which are extremely likely to
be functional), so that average PolyPhen-2 weight was indepen-
dent of allele frequency.
To evaluate the incorporation of computational predictions
within our simulation framework, we needed to generate simu-
lated PolyPhen-2 predictions. We did this by sampling Poly-
Phen-2 scores from their known distributions for functional and
neutral variants (which are deﬁned in our simulations according
to selection coefﬁcient threshold s). The functional and neutral
distributions of PolyPhen-2 scores for damaging and neutral muta-
tions provide a reasonable approximation to PolyPhen-2 scores
that would be generated from empirical sequence data.Application to Empirical Data Sets
We analyzed resequencing data providing established associations
between multiple rare or low-frequency variants and triglyceride
levels, type 1 diabetes, and obesity, as described in previous
work.11,13,14 Data for triglyceride level were split into six groups ac-
cording gender and ethnicity (Non-Hispanic Whites, Non-
Hispanic Blacks, and Hispanics), and normalized rank within the
group was used as a quantitative trait value. For this data set,
following 14 we also considered a discrete phenotype deﬁned by
membership in top or bottom quartiles, with data from remaining
samples ignored for the discrete phenotype analysis. Functional
predictions for each missense variant were calculated with Poly-
Phen-2.17,18 PolyPhen-2 scores were used for computing Bayesian
posterior probabilities, and weights were applied as described
above. Statistical tests were applied to previously associated gene
sets: ANGPTL3 (MIM 604774), ANGPTL4 (MIM 605910),
ANGPTL5 (MIM 607666) for triglyceride levels, IFIH1 (MIM
606951) for type 1 diabetes, and a set of 21 genes for obesity.11,13,14
For each statistical test, the number of permutations was increased
to 100,000, 10,000,000, and 100,000 for the analyses of triglyc-
eride level, type 1 diabetes, and obesity, respectively, for increased
precision in p values.Results
Simulation Framework
We used population-genetics simulations to characterize
the allele-frequency spectrum of rare variants involved in
complex traits and to motivate statistical strategies to iden-
tify such alleles (see Material and Methods). We primarily
focus on the parameter values d ¼ 0.25 and s ¼ 0.001, the
most realistic values, but we also consider other values to
explore robustness of themodel characteristics with respect
to these parameters (see Material and Methods).4 All simu-
lations involved a sample size of 10,000 individuals.
We ﬁrst investigated how phenotypic effects vary with
allele frequency for nonsynonymous variants in this simu-
lation framework. In Figure 1A, we plot the probability 4(p)
that a nonsynonymous variant is functional (i.e., has
a selection coefﬁcient greater than s) as a function of the2010
Figure 1. Probability 4(p) that a Nonsynonymous Variant Is
Functional as a Function of Allele Frequency p
Results are based on 10,000 independent simulations in which we
vary the selection parameter s: s ¼ 0.01 (log10s ¼ 2), s ¼ 0.001
(log10s ¼ 3), or s ¼ 0.0001 (log10s ¼ 4). We also plot the value
4(p) ~1=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
pð1 pÞp (as implicitly assumed by the weighted
approach). All probabilities are normalized by the corresponding
probability for singleton mutations. Panels (A) and (B) are iden-
tical except for the different range of the allele frequency p, with
panel (B) restricted to very rare alleles.allele frequency p, normalized by the value 4(1/2N) for
singleton variants (N ¼ 10,000). Because our model
assumes that the phenotypic distribution is shifted for
these variants, 4(p) is directly related to the expected
phenotypic effect of an allele with frequency p (the distinc-
tion between quantitative and dichotomous phenotypes isThe Ameaddressed below). For comparison, we also plot the value
4(p) ~1=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
pð1 pÞp , as implicitly assumed by the approach
of 16 (see Material and Methods). Figure 1A indicates that
4(p) is a decreasing function of p, but decreasing at a rate
that may differ substantially from1=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
pð1 pÞp , depending
on the value of s. Furthermore, 4(p) is not robust with
respect to model parameters and is likely to vary across
genes and phenotypes.
Of particular interest are variants whose individual
phenotypic association can be conﬁrmed in awell-powered
follow-upgenotypic study in a larger sample. These variants
should be of strong phenotypic effect and sufﬁcient popu-
lation frequency (even though still can be classiﬁed as
low-frequencyvariants).We refer to these variants as ‘‘goldi-
locks’’ variants. For example, an allele with a frequency
of 0.5% could be easily detected by resequencing of 1000
samples. Assuming an effect size of d ¼ 0.25, follow-up
genotyping of 10,000 samples has 57% power to identify
a signiﬁcant association at p ¼ 0.001 (92% power at p ¼
0.05). Our simulations suggest that goldilocks alleles can
be quite common under our simple mutation-selection-
drift model. For d ¼ 0.25 and s ¼ 0.001, we ﬁnd that about
one-eighth of genes affecting the trait are expected to
have at least one functional allele in the frequency range
between 0.5% and 2%. However, this depends on the
strength of selection: functional alleles in this frequency
range are expected to be present in a substantial fraction
of genes with variants under weak selection (s ¼ 0.0001)
affecting the trait, but absent from the population under
strong selection (s ¼ 0.01) (Figure S1, available online). It
is important that methods for detecting association be
effective either in the presence or in the absence of goldi-
locks alleles; otherwise, true associations may be missed.AVariable-Threshold Approach for Pooling Multiple
Rare Variants
On the basis of these results, we were motivated to develop
a statistical strategy for associating multiple rare variants to
a quantitative trait that can adapt to properties of indi-
vidual genes. Different genes may have very different rela-
tionships between allele frequency and functional effect
(Figure 1). In addition, some genes may harbor functional
alleles at higher frequencies, whereas other genes may
have only private functional variants (Figure S1). In our
variable-threshold approach, we group rare alleles together
by optimizing an allele-frequency threshold that maxi-
mizes the difference (as quantiﬁed by a z-score; see
Material and Methods) between distributions of trait
values for individuals with and without rare alleles. The
value of the optimal allele-frequency threshold often varies
considerably, even for ﬁxed simulation parameter values,
but the optimal score is robust to the shape of the z-score
versus frequency-threshold curve. To control type I error,
we apply the same optimization procedure to permuted
data to obtain an exact p value for association (see Material
and Methods and Web Resources).rican Journal of Human Genetics 86, 832–838, June 11, 2010 835
Incorporation of Computational Predictions of
Functional Effects
A major limitation of statistical tests combining multiple
variants is that, without prior functional information
about individual alleles, nonfunctional alleles are
combined together with functional alleles. Statistical
power can in principle be improved by the incorporation
of functional predictions,11,19 and this motivates a system-
atic effort to evaluate formal methods for incorporating
these predictions. We previously developed the PolyPhen
software for predicting the effect of amino acid
changes.17,18 We incorporated PolyPhen-2 scores into our
statistical method as described above (see Material and
Methods). We used the PolyPhen-2 predictions only for
rare variants (MAF < 1%) so as not to exclude the signals
of low-frequency or common variants (see Material and
Methods). (PolyPhen-2 is most effective in predicting the
functional effect of rare variants, which are more likely
to be deleterious than are low-frequency variants, and
the cost of misprediction becomes too high and may
reduce power if the test is dominated by a few low-
frequency variants.)
Evaluation of Statistical Tests on Simulated Data Sets
We evaluated several approaches: a ﬁxed allele-frequency
threshold approach (1% or 5%), a weighted approach
generalizing 16, and our variable-threshold approach with
or without incorporation of simulated PolyPhen predic-
tions (see Material and Methods). We ﬁrst applied these
approaches to quantitative phenotypes, using the simula-
tion framework described above. In each case we
computed statistical signiﬁcance for each of 10,000 inde-
pendent simulations by applying the same test to 1000
different sets of permuted phenotypes, ensuring a properly
controlled type I error rate. We computed power to detect
associations at a signiﬁcance level of either a ¼ 0.05 or a ¼
0.001. (These signiﬁcance levels correspond to candidate-
gene studies that are currently being carried out; whole-
exome studies would require much larger sample sizes to
be well-powered at these effect sizes4). Results are displayed
in Table 1. We see that the variable-threshold approach
outperforms the ﬁxed-threshold approach and the
weighted approach; the improvement is highly statistically
signiﬁcant on the basis of 10,000 independent simulations
(p << 1012). Our results indicate a further increase in
power for incorporating PolyPhen-2 predictions, which is
generally similar to or greater than the beneﬁt of the vari-
able-threshold approach (Table 1). These results are based
on d ¼ 0.25 and s ¼ 0.001 (values considered most real-
istic4), but a wider range of simulations using d ¼ 0.125,
0.25, or 0.50 and s ¼ 0.0001, 0.001, or 0.01 yielded similar
relative results (Table S1). We also obtained similar results
in a simulation in which phenotypes are independent of
selection coefﬁcient (Table S2a), and we veriﬁed that
results are improved by incorporation of PolyPhen-2
predictions arising from either high-quality or low-quality
sequence alignments (Table S2b).836 The American Journal of Human Genetics 86, 832–838, June 11,We repeated the comparison using a dichotomous case-
control phenotype deﬁned by the > 75% and < 25%
percentiles of our simulated quantitative phenotype. We
again see that the variable-threshold approach outper-
forms the weighted approach and that incorporating Poly-
Phen-2 predictions further improves power (Table 2). As
above, all of these results are based on d ¼ 0.25 and
s ¼ 0.001, but a wider range of simulations using
d ¼ 0.125, 0.25, or 0.50 and s ¼ 0.0001, 0.001, or 0.01
yielded similar relative results (Table S3). We also see that
the power that can be attained by using sequence data
from all individuals (Table 1) is higher than the power at-
tained by using sequence data from the top and bottom
phenotype quartiles only (Table 2). We ﬁnally note that
all approaches (not just the variable-threshold approach)
beneﬁted from the incorporation of PolyPhen-2 predic-
tions (Table S4).
The variable-threshold approach was motivated by the
observation that the relationship between allele frequency
and functional effect is not robust with respect to simula-
tion parameters (Figure 1). However, we wondered
whether it could be advantageous to explicitly capture
this relationship for a ﬁxed set of parameters. To investi-
gate this, we implemented a ‘‘cheating’’ approach that
weights variants according to allele frequency p on the
basis of the values of f(p) from our simulations (see Mate-
rial and Methods). Our results should be viewed as an
upper bound on the true power that could be attained by
this speciﬁc approach, because we used the same data to
compute f(p) and to evaluate power. Nonetheless, power
was no better than the variable-threshold approach:
0.187 for a ¼ 0.001 and 0.595 for a ¼ 0.05 (compare to
Table 1). This suggests that the variable-threshold
approach performs well relative to approaches that explic-
itly model the relationship between allele frequency and
functional effect.
Evaluation of Statistical Tests on Empirical Data Sets
We analyzed data from a previous study showing that
multiple rare or low-frequency variants in the ANGPTL3,
ANGPTL4, and ANGPTL5 genes are collectively associated
to low triglyceride levels in a multiethnic population
from the Dallas Heart Study.14 Resequencing data and log
triglyceride levels (adjusted for ethnicity and gender)
were obtained for 3476 samples (see Material and
Methods). We evaluated all statistical approaches as
described above. Although the relative results should be
viewed with caution in light of the small size of these
and other empirical data sets, the variable threshold with
PolyPhen-2 approach performed well (Table 3). Consistent
with our simulations, statistical signiﬁcance was reduced
when using a discrete phenotype deﬁned by top and
bottom quartiles only (p value increases from 0.002 to
0.009 for the weighted approach, from 0.0004 to 0.005
for the variable-threshold approach).
We further analyzed data from a previous study showing
that that multiple rare or low-frequency variants in the2010
Table 3. Results for Three Empirical Data Sets
T1 T5 WE VT VTP
Triglyceride level 0.013 0.00007 0.0020 0.00038 0.00002
Type 1 diabetes 0.001 0.0000002 0.0000004 0.0000008 0.0000002
Obesity 0.032 0.053 0.010 0.010 0.0017
We display p values for T1, T5, WE, VT, and VTP analyses on triglyceride level,
type 1 diabetes, and obesity data sets. All p values are one-sided, reflecting the
direction of the originally reported association.IFIH1 gene are associated with a lower risk of type 1 dia-
betes.13 Resequencing data were obtained for 480 cases
and 480 controls (see Material and Methods). The variable
threshold with PolyPhen approach again performed well
(Table 3). This indicates that the variable-threshold
approach is effective in detecting low-frequency ‘‘goldi-
locks’’ variants associated with phenotype.
Finally, we analyzed data from a previous study showing
that multiple rare or low-frequency variants in 21 genes
(historically associated with monogenic forms of obesity
in humans or mice) are collectively associated to obesity
in a cohort of extremely obese or lean individuals.11 Rese-
quencing data were obtained for 379 extremely obese
samples and 378 lean samples (see Material and Methods).
Once again, the variable threshold with PolyPhen
approach performed well (Table 3). The association signal
in this case is driven primarily by very rare alleles. Overall,
our results on empirical data sets conﬁrm our simulation
results indicating that our approach is robust in detecting
a wide variety of association signals.Discussion
Themotivation for studying rare alleles in complex traits is
based on the hypothesis that rare alleles may have larger
phenotypic effects than common alleles as a consequence
of purifying selection. Although our understanding of the
genetic architecture of complex traits is far from complete,
our simulations suggest that the relationship between
allele frequency and effect size may vary widely with the
intensity of selection, motivating our variable-threshold
approach. We have shown that this approach performs
well on simulated and empirical data, relative to other
methods, and demonstrated that the incorporation of
computational predictions of functional effects provides
a further improvement in power, concordant with recent
work.11,19 The variable-threshold approach is robust to
a range of scenarios, and it will be particularly valuable
when little is known about the likely allele frequencies
and effect sizes of the causal variants. However, there will
always be examples in which other methods perform
better: in the type 1 diabetes example, the true signal is
largely due to MAF > 1% variants, and the inclusion of
lower thresholds (T < 1%) in the variable-threshold test
increases noise and reduces power (Table 3). Conversely,
if the true signal is largely due to singleton or extremelyThe Amerare variants, then methods that explicitly give higher
weights to extremely rare variants may perform better.
A ﬁnal caveat is that population stratiﬁcation may lead to
false-positive associations in this and other approaches. If
sufﬁcient data for inferring genetic ancestry are available,
a solution is to analyze residual phenotypes with respect
to genetic ancestry.
We have focused here on a simpliﬁed scenario involving
individual-level resequencing data and an excess of rare
variants at one phenotypic extreme. However, allele
counts obtained from the resequencing of pools of individ-
uals (with concordant phenotypes within each pool) could
be analyzed in a similar fashion, though variation in the
depth of coverage between pools warrants careful statis-
tical treatment. In addition, if functional rare variants are
expected to affect phenotype in either direction, a straight-
forward extension of ourmethod to capture this signal is to
scale the allele counts (in both original and permuted data)
by the direction of each variant’s association to phenotype,
effectively searching for an excess of rare variants of large
absolute effect. Going forward, the wealth of resequencing
data yet to be generated will shed further light on the true
contribution of rare variants to disease risk.
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Web Resources
The URLs for data presented herein are as follows:
Online Mendelian Inheritance in Man (OMIM) http://www.ncbi.
nlm.nih.gov/omim/
PLINK, http://pngu.mgh.harvard.edu/~purcell/plink/
VT Test Software for implementing the methods described, http://
genetics.bwh.harvard.edu/rare_variantsReferences
1. Altshuler, D., Daly, M.J., and Lander, E.S. (2008). Genetic
mapping in human disease. Science 322, 881–888.
2. Manolio, T.A., Collins, F.S., Cox, N.J., Goldstein, D.B.,
Hindorff, L.A., Hunter, D.J., McCarthy, M.I., Ramos, E.M., Car-
don, L.R., Chakravarti, A., et al. (2009). Finding the missing
heritability of complex diseases. Nature 461, 747–753.
3. Turner, E.H., Lee, C., Ng, S.B., Nickerson, D.A., and Shendure,
J. (2009). Massively parallel exon capture and library-free rese-
quencing across 16 genomes. Nat. Methods 6, 315–316.rican Journal of Human Genetics 86, 832–838, June 11, 2010 837
4. Kryukov, G.V., Shpunt, A., Stamatoyannopoulos, J.A., and
Sunyaev, S.R. (2009). Power of deep, all-exon resequencing
for discovery of human trait genes. Proc. Natl. Acad. Sci.
USA 106, 3871–3876.
5. Pritchard, J.K. (2001). Are rare variants responsible for suscep-
tibility to complex diseases? Am. J. Hum. Genet. 69, 124–137.
6. Kryukov, G.V., Pennacchio, L.A., and Sunyaev, S.R. (2007).
Most rare missense alleles are deleterious in humans: implica-
tions for complex disease and association studies. Am. J. Hum.
Genet. 80, 727–739.
7. Frazer, K.A., Murray, S.S., Schork, N.J., and Topol, E.J. (2009).
Human genetic variation and its contribution to complex
traits. Nat. Rev. Genet. 10, 241–251.
8. Cohen, J.C., Kiss, R.S., Pertsemlidis, A., Marcel, Y.L., McPher-
son, R., and Hobbs, H.H. (2004). Multiple rare alleles
contribute to low plasma levels of HDL cholesterol. Science
305, 869–872.
9. Cohen, J.C., Boerwinkle, E., Mosley, T.H. Jr., and Hobbs, H.H.
(2006). Sequence variations in PCSK9, low LDL, and protec-
tion against coronary heart disease. N. Engl. J. Med. 354,
1264–1272.
10. Romeo, S., Pennacchio, L.A., Fu, Y., Boerwinkle, E., Tybjaerg-
Hansen, A., Hobbs, H.H., and Cohen, J.C. (2007). Popula-
tion-based resequencing of ANGPTL4 uncovers variations
that reduce triglycerides and increase HDL. Nat. Genet. 39,
513–516.
11. Ahituv, N., Kavaslar, N., Schackwitz, W., Ustaszewska, A.,
Martin, J., Hebert, S., Doelle, H., Ersoy, B., Kryukov, G.,
Schmidt, S., et al. (2007). Medical sequencing at the extremes
of human body mass. Am. J. Hum. Genet. 80, 779–791.838 The American Journal of Human Genetics 86, 832–838, June 11,12. Ji, W., Foo, J.N., O’Roak, B.J., Zhao, H., Larson, M.G., Simon,
D.B., Newton-Cheh, C., State, M.W., Levy, D., and Lifton,
R.P. (2008). Rare independentmutations in renal salt handling
genes contribute to blood pressure variation. Nat. Genet. 40,
592–599.
13. Nejentsev, S., Walker, N., Riches, D., Egholm, M., and Todd,
J.A. (2009). Rare variants of IFIH1, a gene implicated in anti-
viral responses, protect against type 1 diabetes. Science 324,
387–389.
14. Romeo, S., Yin,W., Kozlitina, J., Pennacchio, L.A., Boerwinkle,
E., Hobbs, H.H., and Cohen, J.C. (2009). Rare loss-of-function
mutations in ANGPTL family members contribute to plasma
triglyceride levels in humans. J. Clin. Invest. 119, 70–79.
15. Li, B., and Leal, S.M. (2008). Methods for detecting associa-
tions with rare variants for common diseases: application to
analysis of sequence data. Am. J. Hum. Genet. 83, 311–321.
16. Madsen, B.E., and Browning, S.R. (2009). A groupwise associ-
ation test for rare mutations using a weighted sum statistic.
PLoS Genet. 5, e1000384.
17. Ramensky, V., Bork, P., and Sunyaev, S. (2002). Human non-
synonymous SNPs: server and survey. Nucleic Acids Res. 30,
3894–3900.
18. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gera-
simova, A., Bork, P., Kondrashov, A.S., and Sunyaev, S.R.
(2010). A method and server for predicting damaging
missense mutations. Nat. Methods 7, 248–249.
19. Ng, S.B., Turner, E.H., Robertson, P.D., Flygare, S.D., Bigham,
A.W., Lee, C., Shaffer, T., Wong, M., Bhattacharjee, A., Eichler,
E.E., et al. (2009). Targeted capture and massively parallel
sequencing of 12 human exomes. Nature 461, 272–276.2010
